Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

18 January 2021 - preview of changes for February 2021

Pharmaceutical	Change
Abiraterone acetate (Zytiga) tab 250 mg	amended restriction criteria
Alglucosidase alfa (Myozyme) inj 50 mg vial	amended restriction criteria
Aminophylline (DBL Aminophylline) inj 25 mg per ml, 10 ml ampoule	price increase
Amoxicillin (Ibiamox) inj 250 mg, 500 mg and 1 g vial	price increase
Amoxicillin with clavulanic acid (Augmentin) tab 500 mg with clavulanic acid 125 mg	price increase and to be delisted 1 July 2021
Amoxicillin with clavulanic acid (Curam Duo 500/125) tab 500 mg with clavulanic acid 125 mg	new listing and addition of HSS (p’code 2602121)
Arginine inj 500 mg per ml, 10 ml vial	new listing
Benzatropine mesylate (Benztrop) tab 2 mg	price increase
Betaine (Cystadane) powder for oral soln, 180 g	amended restriction criteria
Blood Glucose Lowering Agents	amended therapeutic sub-group name
Cetirizine hydrochloride (Histaclear) oral liq 1 mg per ml, 200 ml	price increase
Diltiazem hydrochloride (Dilzem) tab 30 mg	to be delisted 1 June 2021
Docetaxel (DBL Docetaxel) inj 10 mg per ml, 8 ml vial	price increase
Empagliflozin (Jardiance) tab 10 mg and 25 mg	New listing Tab 10 mg (p’code 2599694) Tab 25 mg (p’code 2599708)
Empagliflozin with metformin hydrochloride (Jardiamet) tab 5 mg with 500 mg and 1,000 mg metformin hydrochloride tab 12.5 mg with 500 mg and 1,000 mg metformin hydrochloride	New listing Tab 5 mg with 500 mg metformin hydrochloride (p’code 2599716) Tab 5 mg with 1,000 mg metformin hydrochloride (p’code 2599724) Tab 12.5 mg with 500 mg metformin hydrochloride (p’code 2599732) Tab 12.5 mg with 1,000 mg metformin hydrochloride (p’code 2599740)
Emtricitabine with tenofovir disoproxil (Teva) tab 200 mg with tenofovir disoproxil 245 mg (300.6 mg as a succinate)	amended restriction criteria
Ergometrine maleate (DBL Ergometrine) inj 500 mcg per ml, 1 ml ampoule	price increase
Erlotinib (Tarceva) tab 100 mg and 150 mg	amended restriction criteria
Etanercept (Enbrel) inj 25 mg autoinjector	new listing (p’code 2602113)
Everolimus (Afinitor) tab 5 mg and 10 mg	amended restriction criteria
Febuxostat (Adenuric) tab 80 mg and 120 mg	amended restriction criteria
Flucloxacillin (Flucloxin) inj 250 mg and 500 mg vial	price increase
Galsulfase (Naglazyme) inj 1 mg per ml, 5 ml vial	amended restriction criteria
Gefitinib (Iressa) tab 250 mg	amended restriction criteria
Heparin sodium (Hospira) inj 1,000 iu and 5,000 iu per ml, 1 ml ampoule	price increase
Hypromellose (Methopt) eye drops 0.5%, 15 ml	new Pharmacode listing (p’code 2603608)
Ibuprofen (Relieve) tab 200 mg	price increase and addition of HSS
Lidocaine [lignocaine] with chlorhexidine (Pfizer) gel 2% with chlorhexidine 0.05%, 10 ml urethral syringes	price increase
Low electrolyte oral feed (e.g. Kindergen) powder 7.5 g protein, 57.6 g carbohydrate and 25.9 g fat per 100 g, 400 g can	new listing
Low electrolyte oral feed (e.g. Kindergen) powder 7.5 g protein, 59 g carbohydrate and 26.3 g fat per 100 g, 400 g can	to be delisted 1 August 2021
Magnesium sulphate (Martindale) inj 2 mmol per ml, 5 ml ampoule	new listing and addition of HSS (p’code 2406438)
Magnesium sulphate (DBL) inj 2 mmol per ml, 5 ml ampoule	price increase and to be delisted 1 July 2021
Medroxyprogesterone acetate (Provera) tab 5 mg and tab 10 mg	price increase
Medroxyprogesterone (Provera HD) tab 100 mg	price increase
Metoprolol tartrate (Metoprolol IV Mylan) inj 1 mg per ml, 5 ml vial	price decrease
Modafinil (Modavigil) tab 100 mg	amended restriction criteria
Morphine sulphate (DBL Morphine Sulphate) inj 5 mg, 10 mg, 15 mg and 30 mg per ml, 1 ml ampoule	price increase
Nedocromil aerosol inhaler 2 mg per dose	delisting delayed until 1 September 2021
Nintedanib (Ofev) cap 100 mg and 150 mg	amended restriction criteria
Nivolumab (Opdivo) inj 10 mg per ml, 4 ml and 10 ml vial	amended restriction criteria
Octreotide (DBL Octreotide) inj 50 mcg, 100 mcg and 500 mcg per ml, 1 ml vial	price increase
Octreotide (Sandostatin LAR) inj 10 mg, 20 mg and 30 mg vial	amended restriction criteria
Pamidronate disodium (Pamisol) inj 3 mg and 6 mg per ml, 10 ml vial	price increase
Pembrolizumab (Keytruda) inj 25 mg per ml, 4 ml vial	amended restriction criteria
Pethidine hydrochloride (DBL Pethidine Hydrochloride) inj 50 mg per ml, 1 ml and 2 ml ampoule	price increase
Phenobarbitone inj 130 mg per ml, 1 ml vial	new listing
Pirfenidone (Esbriet) tab 801 mg and cap 267 mg	amended restriction criteria
Quinine sulphate (Q300) tab 300 mg	to be delisted 1 July 2021
Sapropterin dihydrochloride (Kuvan) tab soluble 100 mg	amended restriction criteria
Sildenafil (Vedafil) tab 25 mg, 50 mg and 100 mg and inj 0.8 mg per ml, 12.5 ml	amended restriction criteria
Sirolimus (Rapamune) tab 1 mg, 2 mg and oral liq 1 mg per ml, 60 ml	amended restriction criteria
Sodium phenylbutyrate (Pheburane) grans 483 mg per g	amended restriction criteria
Sunitinib (Sutent) cap 12.5 mg, 25 mg and 50 mg	amended restriction criteria
Testosterone cipionate (Depo-Testosterone) inj 100 mg per ml, 10 ml vial	price increase
Valganciclovir (Valganciclovir Mylan) tab 450 mg	amended restriction criteria
Vigabatrin tab 500 mg	amended restriction criteria
Vildagliptin (Galvus) tab 50 mg	price decrease
Vildagliptin with metformin hydrochloride (Galvumet) tab 50 mg with 850 mg and 1,000 mg metformin hydrochloride	price decrease
Water (Pfizer) inj 10 ml ampoule	price increase

Find previous months' summaries